Amino Acid Dysregulation Metabotypes Diagnostics for Autism Spectrum Disorders – INSAR 2018 [PDF]
Presented at the International Society for Autism Research (INSAR) Annual Meeting in Rotterdam, Netherlands; May 2018.
NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States. NeuroPointDX developed a test panel for metabolic subtypes (metabotypes) associated with ASD.
Posters & Publications
- Two years following a fecal transplant treatment, test subjects retained improvements in autism symptoms and gut he… https://t.co/fbm7fV32NY5 hours ago
- CEO Elizabeth Donley presented findings from CAMP at the National @TACAfoundation Autism Conference – East Coast. D… https://t.co/p54MQvZlAcyesterday
- Is it time to rethink #AutismAwarenessMonth? https://t.co/tKunyTlAyS #Autism #AutismAcceptanceyesterday